• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Greenwich Lifesciences Inc (NQ: GLSI )

13.44 -0.01 (-0.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Greenwich Lifesciences Inc

< Previous 1 2 Next >
Greenwich LifeSciences Inc. (NASDAQ: GLSI) Near the Top of Equities by Percentage Gain on 2/14
February 14, 2024
Via Investor Brand Network
Greenwich LifeSciences Provides Year End Update
December 29, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023
December 01, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial
August 11, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial
August 03, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Provides Financing Strategy & Corporate Update
July 28, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed
July 12, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Announces Suspension of Share Repurchase Program
July 11, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences to Resume Stock Repurchase Program
May 23, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial & ASCO Meeting
May 23, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences to Participate in Upcoming Jefferies, Wainwright, ASCO and BIO International Conferences
April 20, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Presents Phase IIb Data, Published at AACR 2022, Further Supporting the Role of GP2 in Preventing Metastatic Breast Cancer
April 19, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences to Present at 2022 BIO CEO & Investor Conference
February 03, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Provides Update on Upcoming Phase III Clinical Trial, FLAMINGO-01
February 01, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences to Implement Stock Repurchase Program for up to $10 Million & to Extend Lock-up of Insiders for an Additional 1 Year
January 24, 2022
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences CEO Participates in TD Ameritrade Interview to Discuss 2021 SABCS Poster
December 15, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Announces Presentation of 5 Year Data for GP2 Phase IIb Clinical Trial, Revealing Potential For New T Cell Platform Technology
December 09, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences to Participate in Multiple Interviews and Conferences
December 08, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Expands Role of Industry Expert Dr. F. Joseph Daugherty to Include Medical Monitor for its Upcoming Phase III Clinical Trial
December 07, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Announces Commencement of the First Commercial Line Filling of GP2
December 06, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences CEO Interview to Air on Bloomberg U.S. on the RedChip Money Report
November 18, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences to Participate in Jefferies’ 12th Annual London Healthcare Conference
November 17, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Announces Acceptance of Two Posters at Upcoming 2021 SABCS Breast Cancer Conference
November 11, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Provides Clinical Update on Upcoming Phase III Clinical Trial, FLAMINGO-01
November 10, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Provides Updated Corporate Presentation and Webcasts
November 09, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences to Partner with Susan G. Komen Race for the Cure Houston
September 28, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences to Present at the Benzinga Healthcare Small Cap Conference
September 27, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences to Present at the Cantor Global Healthcare Conference
September 23, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 13, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Provides Updates on Recent and Upcoming Developments
September 09, 2021
From Greenwich LifeSciences, Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap